Your browser doesn't support javascript.
loading
Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.
Gjyshi, Olsi; Xu, Ting; Elhammali, Adnan; Boyce-Fappiano, David; Chun, Stephen G; Gandhi, Saumil; Lee, Percy; Chen, Aileen B; Lin, Steven H; Chang, Joe Y; Tsao, Anne; Gay, Carl M; Zhu, X Ronald; Zhang, Xiaodong; Heymach, John V; Fossella, Frank V; Lu, Charles; Nguyen, Quynh-Nhu; Liao, Zhongxing.
Afiliación
  • Gjyshi O; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xu T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elhammali A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Boyce-Fappiano D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chun SG; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gandhi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen AB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lin SH; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chang JY; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tsao A; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gay CM; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhu XR; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Zhang X; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fossella FV; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lu C; Department of Thoracic-Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liao Z; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: zliao@mdanderson.org.
J Thorac Oncol ; 16(2): 269-277, 2021 02.
Article en En | MEDLINE | ID: mdl-33198942

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Radioterapia de Intensidad Modulada / Terapia de Protones / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Radioterapia de Intensidad Modulada / Terapia de Protones / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos